↓ Skip to main content

HER2/neu (ERBB2) expression and gene amplification correlates with better survival in esophageal adenocarcinoma

Overview of attention for article published in BMC Cancer, January 2019
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (55th percentile)
  • Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

wikipedia
1 Wikipedia page

Citations

dimensions_citation
61 Dimensions

Readers on

mendeley
40 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
HER2/neu (ERBB2) expression and gene amplification correlates with better survival in esophageal adenocarcinoma
Published in
BMC Cancer, January 2019
DOI 10.1186/s12885-018-5242-4
Pubmed ID
Authors

Patrick Sven Plum, Florian Gebauer, Max Krämer, Hakan Alakus, Felix Berlth, Seung-Hun Chon, Lars Schiffmann, Thomas Zander, Reinhard Büttner, Arnulf Heinrich Hölscher, Christiane Josephine Bruns, Alexander Quaas, Heike Loeser

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 40 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 40 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 5 13%
Researcher 4 10%
Student > Ph. D. Student 4 10%
Student > Doctoral Student 3 8%
Student > Master 3 8%
Other 7 18%
Unknown 14 35%
Readers by discipline Count As %
Medicine and Dentistry 7 18%
Biochemistry, Genetics and Molecular Biology 6 15%
Nursing and Health Professions 2 5%
Pharmacology, Toxicology and Pharmaceutical Science 2 5%
Immunology and Microbiology 2 5%
Other 5 13%
Unknown 16 40%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 March 2022.
All research outputs
#7,684,170
of 23,381,576 outputs
Outputs from BMC Cancer
#2,138
of 8,458 outputs
Outputs of similar age
#158,827
of 439,923 outputs
Outputs of similar age from BMC Cancer
#47
of 176 outputs
Altmetric has tracked 23,381,576 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,458 research outputs from this source. They receive a mean Attention Score of 4.4. This one has gotten more attention than average, scoring higher than 68% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 439,923 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 55% of its contemporaries.
We're also able to compare this research output to 176 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.